Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:01 AM ET 8-K
Leadership Change Hartford Insurance Group, Inc. HIG

Hartford Insurance Group Leadership Change

The Hartford announced that Christopher J. Swift will resign as CEO effective March 1, 2027, transitioning to the role of Executive Chair before retiring in late 2027. A. Morris Tooker, the company's current President, has been appointed to succeed Swift as CEO and will join the Board of Directors effective October 1, 2026. The Board approved a target total annual compensation opportunity for Mr. Tooker of $12 million effective upon his appointment as CEO.

6:46 AM ET 8-K
M&A Deal Hormel Foods Corp HRL

Hormel Foods Signs $1.05B M&A Deal with Brakebush Brothers, LLC

Hormel Foods has entered into a definitive agreement to acquire Brakebush Brothers, LLC, a leading value-added chicken company, for $1.055 billion in cash. The acquisition is intended to strengthen Hormel's position in the growing chicken protein category and expand its foodservice segment capabilities. The transaction is expected to close in the first quarter of Hormel's fiscal 2027.

Value
$1.05B
Counterparty
Brakebush Brothers, LLC
6:39 AM ET 8-K/A
Capital Raise Zedge, Inc. ZDGE

Zedge Capital Raise of $7.67M

Zedge, Inc. completed a private placement of 2,616,447 shares of Class B common stock and warrants to purchase 2,354,803 shares, raising $7.675 million in gross proceeds. The investment was led by Vice Chairman Howard Jonas through Chartwell Holding LLC, with participation from board member Elliot Gibber. The company intends to use the capital to accelerate the growth of its B2B AI data business, DataSeeds.AI.

Value
$7.67M
Counterparty
Chartwell Holding LLC
6:31 AM ET 8-K
Loan & Debt Hyperscale Data, Inc. GPUS

Hyperscale Data $21M Debt Financing with JGB Capital, LP

Hyperscale Data and its subsidiaries entered into an amendment to their existing loan agreement, facilitating an additional $21 million loan to affiliate Ault & Company. The amendment also extends the maturity date of all loans under the agreement to December 14, 2027, with the new debt secured by various company assets and mortgages.

Value
$21M
Counterparty
JGB Capital, LP
Term
through Dec 14, 2027
6:30 AM ET Form 4
Insider Buying ASP Isotopes Inc. ASPI

ASP Isotopes Director Robert John Andrew Ryan Buys $21.6K of Stock

Robert John Andrew Ryan, Director, bought 8,000 shares of ASP Isotopes Inc. at $2.70 a share, worth $21.6K in total on Sep 28, 2026. Shares held after the trade: 660,222 (+1.2%).

Value
$21.6K
Shares
8,000
Price
$2.70
Role
Director
Holding change
+1.2%
Trade date
Sep 28, 2026
6:21 AM ET 8-K
Investor Presentation Conduent Inc CNDT

Conduent Investor Presentation

Conduent is hosting an Investor Day in New York City to outline its 'ASCEND 2026-28' strategic framework, focusing on long-term growth, portfolio priorities, and cost reduction initiatives. The presentation includes financial targets through fiscal year 2028, including expectations for revenue growth, Adjusted EBITDA margins, and leverage reduction following the divestitures of its Transit and Tolling businesses.

6:15 AM ET 8-K
Capital Raise Addentax Group Corp. ATXG

Addentax Group Capital Raise of $2.5M

Addentax Group Corp. entered into a private placement agreement with investor Chan Kai Sang to sell 520,834 shares of common stock at $4.80 per share. The transaction is expected to generate gross proceeds of approximately $2.5 million, which the company intends to use for general corporate purposes and strategic investments.

Value
$2.5M
Counterparty
Chan Kai Sang
6:10 AM ET 8-K
Deal Termination Sagimet Biosciences Inc. SGMT

Sagimet Biosciences Deal Termination with Leerink Partners LLC

Sagimet Biosciences has suspended and terminated its at-the-market (ATM) offering prospectus supplement related to its Series A common stock. The company will not make any further sales under the sales agreement with Leerink Partners LLC until a new prospectus or registration statement is filed. The filing also included an updated investor presentation and clinical trial results for denifanstat in acne vulgaris.

Counterparty
Leerink Partners LLC
6:10 AM ET 8-K
M&A Deal Marygold Companies, Inc. MGLD

Marygold Companies M&A Deal with Madison Dearborn Partners

The Marygold Companies provided a status update on its previously announced definitive merger agreement with Madison Dearborn Partners (MDP), where MDP will acquire all outstanding shares for $2.00 per share. The company confirmed that stockholders representing 75% of the voting power have already delivered written consent approving the deal, and as a result, the company is no longer permitted to pursue alternative acquisition proposals.

Counterparty
Madison Dearborn Partners
6:08 AM ET 8-K
Financial Results Cal-Maine Foods Inc CALM

Cal-Maine Foods Financial Results

Cal-Maine Foods reported first quarter fiscal 2027 net sales of $539.6 million, a 41.5% decrease year-over-year, and a net loss of $58.6 million. The results were significantly impacted by a 59.3% decrease in average selling prices for conventional shell eggs due to an industry supply imbalance, despite growth in the Specialty Shell Eggs and Prepared Foods segments.

Term
Q1 2027
Earnings call
Sep 30, 2026, 9:00 AM ET

“Our first-quarter results reflect both the current point in the conventional shell egg cycle and the continued evolution of Cal-Maine Foods’ earnings model. Conventional Shell Egg pricing remains under pressure from an industry supply imbalance, while underlying demand remains healthy. At the same time, Specialty Shell Eggs and Prepared Foods now represent approximately 54% of our net sales, demonstrating the progress we have made in broadening our business. We remain focused on our foundational Conventional Shell Egg business while scaling Specialty and Prepared Foods and converting the investments we have made into profitable growth.”

Sherman Miller, president and chief executive officer of Cal-Maine Foods
6:04 AM ET 8-K
M&A Deal OceanLight Acquisition Corp OCLT

OceanLight Acquisition Signs $1B M&A Deal with AIRE Inc.

OceanLight Acquisition Corporation (OCLT), a SPAC, has entered into a definitive merger agreement to acquire AIRE Inc., a home textile and green sleep technology company, at an enterprise value of $1.0 billion. Upon closing, the combined entity will be known as AIRE Global Group Inc. and is expected to remain listed on the Nasdaq. The transaction will involve the issuance of 100 million shares to AIRE shareholders at a value of $10.00 per share.

Value
$1B
Counterparty
AIRE Inc.
6:04 AM ET 8-K
Shareholder Meeting AeroVironment Inc AVAV

AeroVironment Shareholder Meeting

AeroVironment held its 2026 Annual Meeting of Stockholders where five directors were elected to one-year terms. Stockholders also ratified the selection of Deloitte & Touche LLP as independent auditors for fiscal year 2027 and approved executive compensation in an advisory vote.

Term
1 year
6:04 AM ET Form 4
Insider Buying Miniso Group Holding Ltd MNSO

Miniso Group Holding VP and CFO Jingjing Eason Zhang Buys $340K of Stock

Jingjing Eason Zhang, VP and CFO, bought 150,600 shares of Miniso Group Holding Ltd at $2.26 a share, worth $340K in total on Sep 29, 2026. Shares held after the trade: 394,474 (+61.8%).

Value
$340K
Shares
150,600
Price
$2.26
Role
VP and CFO
Holding change
+61.8%
Trade date
Sep 29, 2026
6:04 AM ET 8-K
Business Update Artificial Intelligence Technology Solutions Inc. AITX

Artificial Intelligence Technology Solutions Business Update

Artificial Intelligence Technology Solutions' subsidiary, RAD, received an additional order for one RIO 360 unit from an existing global healthcare technology client. This follows a previous order from the same customer earlier in the month and is intended for after-hours trespass deterrence at a second location.

Counterparty
unnamed global healthcare technology customer
6:04 AM ET 8-K
Other 8-K Filing DBV Technologies S.A. DBVT

DBV Technologies Other 8-K Filing

DBV Technologies has submitted a Biologics License Application (BLA) to the U.S. FDA for its VIASKIN Peanut Patch for children aged 4-7 years. The submission is based on positive Phase 3 VITESSE trial results and marks the company's transition toward a commercial-stage organization. The company has requested Priority Review for the application.

Counterparty
FDA
6:02 AM ET 8-K
Business Update Ares Management Corp ARES

Ares Management Business Update

Ares Management Corporation provided a preliminary estimate for its realized net performance income for the third quarter ending September 30, 2026. The company expects approximately $10 million in realized net performance income, a slight increase from the $9 million reported in the same period the prior year.

Term
Q3 2026
6:02 AM ET 8-K
Stock Buyback News Corp NWSA

News Announces $1B Stock Buyback

News Corp provided a daily update on its $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The program authorizes the company to buy back outstanding shares of both Class A and Class B common stock from time to time in the open market. The filing includes specific daily transaction notifications for Class A common stock repurchases.

Value
$1B
6:02 AM ET 8-K
Other 8-K Filing Invest Acquisition Corp IVCBF

Invest Acquisition Other 8-K Filing

Invest Acquisition Corp shareholders approved an amendment to extend the company's business combination deadline from December 17, 2027, to December 17, 2029. In connection with the extension, holders of 1,801,349 Class A ordinary shares elected to redeem their shares for approximately $22.2 million from the trust account.

6:01 AM ET 8-K
Other 8-K Filing IB Acquisition Corp. IBAC

IB Acquisition Other 8-K Filing

IB Acquisition Corp. (IBAC) held a special meeting where stockholders approved an extension to the deadline for completing its initial business combination from September 28, 2026, to March 28, 2027. The company filed a charter amendment to formalize this extension and updated its trust agreement to reflect the new liquidation and redemption timeline.

Term
6 months
6:01 AM ET 8-K
Shareholder Meeting Barnes & Noble Education, Inc. BNED

Barnes & Noble Education Shareholder Meeting

Barnes & Noble Education held its 2026 Annual Meeting of Stockholders on September 24, 2026, where shareholders elected six directors to the board. Stockholders also approved an amendment to the company's Equity Incentive Plan to increase the number of authorized shares, ratified the appointment of BDO USA, P.C. as independent auditors, and approved executive compensation on an advisory basis.

6:00 AM ET 8-K
Divestiture Reliance Global Group, Inc. XGPU

Reliance Global Group Divestiture to Altruis Benefit Management, LLC for $8M

Reliance Global Group's subsidiary, Altruis Benefit Consultants, sold substantially all assets of its employee benefits insurance agency business to Altruis Benefit Management, LLC for $8 million. The consideration consists of approximately $4.44 million in cash, a $3.1 million secured promissory note, and $461,729 in holdbacks, with potential earnout payments of up to $1 million based on future revenue growth. The transaction closed simultaneously with the signing of the asset purchase agreement on September 23, 2026.

Value
$8M
Counterparty
Altruis Benefit Management, LLC
6:00 AM ET 8-K
Capital Raise Stonepeak-Plus Infrastructure Fund LP

Stonepeak-Plus Infrastructure Fund Capital Raise of $52.7M

Stonepeak-Plus Infrastructure Fund LP sold unregistered limited partnership units to third-party investors for approximately $52.7 million on September 1, 2026. The sale was part of a continuous private offering that has raised approximately $1.92 billion since its inception in May 2025.

Value
$52.7M
Counterparty
Third party investors
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CFO Brandi Roberts Sells $123K of Stock

Brandi Roberts, CFO, sold 3,377 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $123K in total on Sep 25, 2026. Shares held after the trade: 394,528 (-0.8%).

Value
$123K
Shares
3,377
Price
$36.57
Role
CFO
Holding change
-0.8%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CLO Mark Sullivan Sells $514K of Stock

Mark Sullivan, CLO, sold 14,051 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $514K in total on Sep 25, 2026. Shares held after the trade: 494,228 (-2.8%).

Value
$514K
Shares
14,051
Price
$36.57
Role
CLO
Holding change
-2.8%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics Chief Commercial Officer Matthew T. Wiley Sells $113K of Stock

Matthew T. Wiley, Chief Commercial Officer, sold 3,097 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $113K in total on Sep 25, 2026. Shares held after the trade: 359,036 (-0.9%).

Value
$113K
Shares
3,097
Price
$36.57
Role
Chief Commercial Officer
Holding change
-0.9%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CEO Robert Barrow Sells $1.15M of Stock

Robert Barrow, CEO, sold 31,550 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $1.15M in total on Sep 25, 2026. Shares held after the trade: 2,213,090 (-1.4%).

Value
$1.15M
Shares
31,550
Price
$36.57
Role
CEO
Holding change
-1.4%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Becton Dickinson & Co BDX

Becton Dickinson & EVP, Chief Revenue Officer Michael Feld Sells $14K of Stock

Michael Feld, EVP, Chief Revenue Officer, sold 76 shares of Becton Dickinson & Co at $183.70 a share, worth $14K in total on Sep 28, 2026. Shares held after the trade: 19,644 (-0.4%).

Value
$14K
Shares
76
Price
$183.70
Role
EVP, Chief Revenue Officer
Holding change
-0.4%
Trade date
Sep 28, 2026
2:20 AM ET Form 4
Insider Selling Definium Therapeutics, Inc. DFTX

Definium Therapeutics CMO Daniel Karlin Sells $397K of Stock

Daniel Karlin, CMO, sold 10,853 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $397K in total on Sep 25, 2026. Shares held after the trade: 792,846 (-1.4%).

Value
$397K
Shares
10,853
Price
$36.57
Role
CMO
Holding change
-1.4%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling Photronics Inc PLAB

Photronics SVP & GM of FPD Ops Han Kyung Park Sells $289K of Stock

Han Kyung Park, SVP & GM of FPD Ops, sold 9,500 shares of Photronics Inc at $30.37 a share, worth $289K in total on Sep 25, 2026. Shares held after the trade: 66,000 (-12.6%).

Value
$289K
Shares
9,500
Price
$30.37
Role
SVP & GM of FPD Ops
Holding change
-12.6%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Buying ADARx Pharmaceuticals, Inc. ADRX

ADARx Pharmaceuticals Director Simeon George Buys $27.2M of Stock

Simeon George, Director, bought 1,600,000 shares of ADARx Pharmaceuticals, Inc. at $17.00 a share, worth $27.2M in total on Sep 28, 2026. Shares held after the trade: 592,593.

Value
$27.2M
Shares
1,600,000
Average price
$17.00
Role
Director
Trade date
Sep 28, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.